Revance Therapeutics Inc., a Mountain View, Calif.-based drug company focused on the aesthetic medicine and personal wellness categories, has raised $8 million in venture debt funding from Leader Ventures and Horizon Technology Finance. It had previously raised around $64 million in VC funding from Bio*One Capital, Medicis Pharmaceuticals Corp., Essex Woodlands Healthcare Ventures, Vivo Ventures, Technology Partners, Shepherd Ventures and Palo Alto Investors.
